Carboplatin is a platinum analogue with activity reported in head and neck cancer. We conducted a phase II trial with 14 patients who had recurrent head and neck cancer. They were treated with carboplatin 300 mg/m2 intravenously (I.V.) and bleomycin 30 units I.V. every 4 weeks. No responses were obs
Phase II study of docetaxel and topotecan combination chemotherapy in patients with advanced head and neck cancer
โ Scribed by RobertI. Haddad; DavidA. Echo
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 161 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Comb in a tio n Ch em o therapy with Cis-Dia m m in e dic h lo ropla tin um , On c o vin , an d Bleo m ycin (COB) in Advanced Head and Neck Cancer Phase I1 MAGID H. AMER, MD, FRCS (ENG.), FRCP(C),\* RONALD M. IZBICKI, DO,\* V. K. VAITKEVICIUS, MD, FACP,t AND MUHYI AL-SARRAF, MD, FRCP(C), FACP\* Twen
Piritrexim (PTX) is a newly developed lipid-soluble folate antagonist that crosses the cell membrane by a simple, rapid, carrier-independent diffusion process. A Phase II study was conducted to evaluate the activity of PTX in 34 patients with previously chemotherapy-naive squamous cell cancer of the